Drug company (FDA labeler)
Modavar Pharmaceuticals LLC
NDC labeler code: 72241
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- OlanzapineZyprexa, Zyprexa Zydis, Olanzapine Intramuscular · 6 products
- RivastigmineRivastigmine Transdermal System, Exelon · 4 products
- NebivololBystolic · 4 products
- CelecoxibCelebrex, Vyscoxa, Elyxyb - Celecoxib · 4 products
- AcyclovirZovirax, Avaclyr · 3 products
- ParoxetinePaxil, Paxil CR, Brisdelle · 3 products
- Olmesartan medoxomilBenicar · 3 products
- Hydralazine hydrochloride3 products
- Telmisartan3 products
- TizanidineZanaflex, Ontralfy · 3 products
- OfloxacinOcuflox · 3 products
- FluoxetineProzac · 3 products
- SildenafilViagra, Vybrique, Revatio · 3 products
- Glyburide3 products
- Venlafaxine hydrochlorideEffexor XR · 3 products
- Nateglinide2 products
- ErythromycinEry, Ery-Tab · 2 products
- BupropionWellbutrin SR, Aplenzin, Wellbutrin XL · 2 products
- Raloxifene hydrochlorideEvista · 1 product
- Folic acidQuiofic · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| November 8, 2024 | ANDA210682 | Olmesartan medoxomil OLMESARTAN MEDOXOMIL | Cadila Pharms Ltd |
| November 28, 2023 | ANDA218045 | Sildenafil SILDENAFIL CITRATE | Cadila Pharms Ltd |
| February 24, 2023 | ANDA210022 | Olanzapine OLANZAPINE | Cadila Pharms Ltd |
| December 17, 2021 | ANDA208717 | Nebivolol NEBIVOLOL HYDROCHLORIDE | Cadila Pharms Ltd |
| August 27, 2021 | ANDA212645 | Paroxetine PAROXETINE HYDROCHLORIDE | Cadila Pharms Ltd |
| June 28, 2021 | ANDA213628 | Erythromycin ERYTHROMYCIN | Cadila Pharms Ltd |
| August 18, 2020 | ANDA211324 | Raloxifene hydrochloride RALOXIFENE HYDROCHLORIDE | Cadila Pharms Ltd |
| January 16, 2020 | ANDA208606 | Bupropion BUPROPION HYDROCHLORIDE | Cadila Pharms Ltd |
| November 14, 2019 | ANDA208701 | Celecoxib CELECOXIB | Cadila Pharms Ltd |
| August 29, 2019 | ANDA211323 | Venlafaxine hydrochloride VENLAFAXINE HYDROCHLORIDE | Cadila Pharms Ltd |
| May 23, 2019 | ANDA206993 | Fluoxetine FLUOXETINE HYDROCHLORIDE | Cadila Pharms Ltd |
| April 19, 2019 | ANDA206432 | Nateglinide NATEGLINIDE | Cadila Pharms Ltd |
| March 26, 2019 | ANDA210021 | Tizanidine TIZANIDINE HYDROCHLORIDE | Cadila Pharms Ltd |
| January 4, 2019 | ANDA203379 | Glyburide GLYBURIDE | Cadila Pharms Ltd |
| July 25, 2017 | ANDA208605 | Telmisartan TELMISARTAN | Cadila Pharms Ltd |
| February 13, 2017 | ANDA203844 | Rivastigmine RIVASTIGMINE TARTRATE | Cadila Pharms Ltd |
| September 18, 2014 | ANDA091656 | Ofloxacin OFLOXACIN | Cadila Pharms Ltd |
| September 18, 2014 | ANDA203845 | Hydralazine hydrochloride HYDRALAZINE HYDROCHLORIDE | Cadila Pharms Ltd |
| March 6, 2014 | ANDA201445 | Acyclovir ACYCLOVIR | Cadila Pharms Ltd |
| January 27, 2014 | ANDA202437 | Folic acid FOLIC ACID | Cadila Pharms Ltd |
| November 15, 2013 | ANDA202168 | Acyclovir ACYCLOVIR | Cadila Pharms Ltd |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
No recall of these products (by NDC code) appears in the FDA enforcement reports.
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026